Literature DB >> 20567947

Percutaneous tibial nerve stimulation and overactive bladder.

Kamran P Sajadi1, Howard B Goldman.   

Abstract

Entities:  

Year:  2010        PMID： 20567947     DOI： 10.1007/s11934-010-0126-4

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


× No keyword cloud information.
  9 in total

Review 1.  The placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms.

Authors:  Jules H Schagen van Leeuwen; Ramiro Castro; Michael Busse; Bart L H Bemelmans
Journal:  Eur Urol       Date:  2006-05-19       Impact factor: 20.096

2.  Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial.

Authors:  Kenneth M Peters; Scott A Macdiarmid; Leslie S Wooldridge; Fah Che Leong; S Abbas Shobeiri; Eric S Rovner; Steven W Siegel; Susan B Tate; Barry K Jarnagin; Peter L Rosenblatt; Brian A Feagins
Journal:  J Urol       Date:  2009-07-18       Impact factor: 7.450

3.  Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study.

Authors:  F E Govier; S Litwiller; V Nitti; K J Kreder ; P Rosenblatt
Journal:  J Urol       Date:  2001-04       Impact factor: 7.450

4.  Percutaneous tibial nerve stimulation for the treatment of urinary frequency, urinary urgency, and urge incontinence: results from a community-based clinic.

Authors:  Leslie Saltzstein Wooldridge
Journal:  Urol Nurs       Date:  2009 May-Jun

5.  Posterior tibial nerve stimulation in the treatment of voiding dysfunction: urodynamic data.

Authors:  Vera Vandoninck; Michael R van Balken; Enrico Finazzi Agrò; John P F A Heesakkers; Frans M J Debruyne; Lambertus A L M Kiemeney; Bart L H Bemelmans
Journal:  Neurourol Urodyn       Date:  2004       Impact factor: 2.696

6.  The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction.

Authors:  Sahin Kabay; Sibel Canbaz Kabay; Mehmet Yucel; Hilmi Ozden; Zahide Yilmaz; Ozgen Aras; Bahar Aras
Journal:  Neurourol Urodyn       Date:  2009       Impact factor: 2.696

Review 7.  A review of adherence to drug therapy in patients with overactive bladder.

Authors:  Ramandeep K Basra; Adrian Wagg; Christopher Chapple; Linda Cardozo; David Castro-Diaz; Montserrat Espuna Pons; Mike Kirby; Ian Milsom; Mark Vierhout; Philip Van Kerrebroeck; Con Kelleher
Journal:  BJU Int       Date:  2008-07-04       Impact factor: 5.588

8.  Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder.

Authors:  Scott A MacDiarmid; Kenneth M Peters; S Abbas Shobeiri; Leslie S Wooldridge; Eric S Rovner; Fah Che Leong; Steven W Siegel; Susan B Tate; Brian A Feagins
Journal:  J Urol       Date:  2010-01       Impact factor: 7.450

9.  Economic costs of overactive bladder in the United States.

Authors:  Michael L Ganz; Amy M Smalarz; Tracey L Krupski; Jennifer T Anger; Jim C Hu; Kim U Wittrup-Jensen; Chris L Pashos
Journal:  Urology       Date:  2009-12-29       Impact factor: 2.649
  9 in total
  1 in total

Review 1.  Urology as rehabilitation medicine: a literature review.

Authors:  Tae Beom Kim; Chang Hee Kim; Kwang Taek Kim; Sang Jin Yoon; Kyung Jin Chung
Journal:  J Exerc Rehabil       Date:  2018-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.